TSXV:CLAS.H - Post by User
Post by
Red~Oneon Apr 24, 2022 7:30pm
208 Views
Post# 34627723
Other N.O. News
Other N.O. News Beyond Air® to Participate in Three Upcoming Medical Conferences
GARDEN CITY, N.Y., April 18, 2022 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension and, through its affiliate Beyond Cancer, ultra-high concentration nitric oxide (UNO) for the treatment of solid tumors, today announced that the Company is scheduled to present new data at three upcoming medical conferences.